Objective: To test the hypothesis that urinary incontinence (UI) is associated with incident parkinsonism in older adults. Methods: We used data from 2,617 older persons without dementia. Assessment included baseline self-report UI and annual structured exam which assessed parkinsonian signs, motor performances, cognitive function, and self-report disabilities. We used a series of Cox proportional hazards models to examine the association of UI with parkinsonism and adverse health outcomes and a mixed-effect model to examine the association of UI with the annual rate of cognitive decline. In decedents, regression models were used to examine if UI proximate to death was related to postmortem indices of neuropathologies. Results: At baseline, more than 45% of participants reported some degree of UI. Over an average of nearly 8 years of follow-up, UI was associated with incident parkinsonism (hazard ratio [HR] = 1.07, 95% CI = 1.02, 1.12), death (HR = 1.07, 95% CI = 1.03, 1.11), incident ADL disability (HR = 1.11, 95% CI = 1.07, 1.16), and incident mobility disability (HR = 1.07, 95% CI = 1.02, 1.13). UI was not related to incident MCI (HR = 1.02, 95% CI = 0.97, 1.07), incident AD dementia (HR = 1.00, 95% CI = 0.95, 1.05) or to the rate of cognitive decline (Estimate = −.002, standard error = .002, p = .167). In 1,024 decedents with brain autopsy, UI proximate to death was related to PD pathology (Lewy body pathology and nigral neuronal loss), but not Alzheimer's disease pathology or other age-related neuropathologies. Conclusion: UI in older adults is associated with incident parkinsonism and may identify older adults at risk for accumulating PD brain pathology.
Urinary incontinence (UI) may be caused by diverse neurologic and non-neurologic causes and its prevalence increases with age (1) . UI can be an early manifestation of cognitive and gait impairment in older adults, for example, in cases of hydrocephalus, and may be more prevalent in older adults with cognitive impairment (2) (3) (4) . In addition, there has been increased recognition that impaired micturition is common in neurodegenerative disorders such as Parkinson's disease (PD) and may manifest early in the course of the disease before the onset of traditional motor symptoms (5) (6) (7) . Moreover, recent autopsy and brain imaging studies suggest that alpha-synuclein and other age-related pathologies accumulate in brains of older adults without a clinical diagnosis of PD and are associated with parkinsonism (5) . However, while UI and parkinsonian signs are both common in older adults without PD, longitudinal studies examining whether UI is associated with incident parkinsonism in older adults are lacking. Furthermore, despite the essential role of the brain in micturition, it is not known if UI proximate to death in older adults is associated with indices of brain neuropathology including PD and other age-related neuropathologies.
We tested the hypothesis that UI is associated with incident parkinsonism in community-dwelling older adults. We used data from more than 2,500 older persons without dementia at baseline participating in one of two community-based cohort studies of common chronic conditions of aging: the Religious Orders Study (ROS) or the Rush Memory and Aging Project (MAP) (8, 9) . In this study, we categorized parkinsonism based on the presence of two or more cardinal signs of parkinsonism (gait or posture disturbance, bradykinesia, rigidity, and tremor) which has been validated in prior publications (10, 11) .
First, we examined if UI was associated with incident parkinsonism. Then since the pathologic basis for parkinsonism may vary in older adults with and without a clinical diagnosis of PD (10), we examined a sensitivity analysis excluding cases with a clinical diagnosis of PD. In further analyses, we examined if baseline UI was also associated with other adverse health outcomes including survival, incident disability, and incident cognitive impairment. In more than 1,000 decedents who underwent brain autopsy, we tested whether postmortem indices of PD pathology and other neuropathologies are associated with UI proximate to death.
Methods

Subjects
Participants are from the ROS and MAP, two ongoing longitudinal clinical-pathological investigations of aging and cognition (8, 9) . ROS, which began in 1994, recruits older Catholic nuns, priests, and lay brothers from approximately 40 groups in the United States. MAP, which began in 1997, recruits residents of continuous care retirement communities and, subsidized housing, and other residents through local Churches and social service agencies serving minorities and low-income elderly in metropolitan Chicago. Participants enroll without known dementia, undergo annual testing, and all have agreed to brain autopsy at death. Participants sign an informed consent and Anatomical Gift Act. The studies operate in accordance with the latest version of the Declaration of Helsinki and were approved by the Institutional Review Board of Rush University Medical Center.
Both studies employ common structured clinical assessment and postmortem data collection allowing combined analyses of their data. More than 3,076 persons have enrolled since these studies began and participation in the annual follow-up evaluations exceeds 90% of survivors. At the time of these analyses there were 2,617 enrolled in both studies who did not have clinical dementia at baseline, had completed both baseline assessment of UI and had one or more follow-up assessments. We excluded 186 with clinical dementia at baseline, 261 who did not have follow-up (either they died before the first followup or had not been in the study long enough) and 12 cases with missing data which left 2,617 persons included in these analyses.
Clinical Assessment, Cognitive, and Clinical Diagnoses
Each subject had a uniform structured evaluation which included a medical history, neurological and medical examination, and cognitive testing. Each year, trained technicians administered 17 cognitive tests. Raw sores on each test were converted to z scores, using the baseline mean and standard deviation (SD), and the z scores were averaged to yield the composite global cognition score as described in prior publications. The Mini-Mental State Examination (MMSE) (12) used only to describe the cohort was also assessed but was not included in the global cognition score. (22) . Detailed information about the individual cognitive tests and the formation of the composite measure of cognition is published elsewhere (8) .
The cognitive test data were reviewed by an experienced neuropsychologist who determined if cognitive impairment was present. A clinician, experienced in the evaluation of older persons, reviewed all available data to determine a cognitive diagnosis at each visit using criteria previously described. Dementia and its causes was diagnosed using the guidelines of the joint working group of the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer's Disease and Related Disorders Association (23) . Individuals with cognitive impairment who did not meet dementia criteria were diagnosed with mild cognitive impairment (MCI). Individuals without dementia or MCI were classified as having no cognitive impairment (NCI). A diagnosis of PD was based on the history of PD for which the participant was treated with levodopa or other dopaminergic agents (24) .
Assessment of UI
Participants rated the frequency of episodes of incontinence during the previous year using an ordinal scale (0-4): 0 = never; 1 = ≤1 episode/month; 2 = episodes on 2-4 days/month; 3 = episodes on 2-4 days/week; 4 = episodes on 5-7 days/week. After a review of three ways to represent this measure in these analyses (four indicator variables for the four levels of incontinence reported, a single variable with 1 degree of freedom, or a binary measure corresponding to any incontinence), we concluded that the use of four indicators does not improve the fit of the model. Therefore, we present analyses with the numerical scale treated as one variable. Each point on the scale corresponds to an increased frequency of baseline incontinence as described previously.
Assessment of Parkinsonism and Other Adverse Health Outcomes
Parkinsonism was based on the presence of two or more cardinal signs of parkinsonism Trained nurse clinicians administered the mUPDRS. There were 26 items from the mUPDRS which assessed four parkinsonian signs (gait or posture disturbance, bradykinesia, rigidity, and tremor). A sign was considered present if two or more of its' respective items had at least a score of 1 indicating a mild abnormality. Parkinsonism was present if two or more of the four signs were present on clinical exam (10) .
Mortality: When an autopsy is obtained, date of death is known promptly. When no autopsy is obtained, we obtain information on date of death from an interview with a knowledgeable informant or searches of public databases as previously described.
Disability was assessed annually via two self-report instruments. Basic activities of daily living (ADLs) were assessed using 6 items from the Katz scale (25) . Mobility disability was assessed using the Rosow-Breslau scale, which assesses three walking performances (26) .
Other Clinical Covariates
Sex and years of education were recorded at the baseline interview. Age in years was computed from self-reported date of birth and clinical evaluation date.
Seven chronic diseases were documented at baseline based on self-report of hypertension, diabetes, myocardial infarction, cancer, thyroid disease, head trauma, and stroke (9) . Since both high and low body mass index (BMI) can be associated with adverse health outcomes we included linear and quadratic terms for BMI.
Postmortem Indices
Brain removal, tissue sectioning and preservation, and a uniform gross and microscopic examination with quantification of postmortem indices followed a standard protocol (27) . The postmortem examination assessed nine common neuropathologies including: LBD pathology and nigral neuronal loss as well as AD pathology, TDP-43, chronic macroinfarcts, microinfarcts, arteriolosclerosis, atherosclerosis, and cerebral amyloid angiopathy as described in prior publications (28, 29) .
Statistical Analyses
We first examined the crude associations of UI with age, sex, and education and other covariates at baseline. We obtained Spearman's rank correlation ρ to test the associations with age and education. To examine whether UI was associated with adverse health outcomes, we employed a series of discrete-time Cox proportional hazards model with terms to adjust for age, sex, and education and a term for UI. We added additional terms to examine whether other factors attenuated the association of UI and incident parkinsonism.
We used a linear mixed-effects model to examine whether baseline UI was related to the level and the rate of change in global cognition during the study period (30) . In this model (Table 3) , repeated measures of global cognition were used as the longitudinal outcome. The primary model predictors included a total of nine terms for fixed effects and random effects for level and time. The first term was for Time in years since the baseline. This coefficient represents the annual rate of change in global cognition. Then a term for UI shows the cross-sectional association of baseline UI with level of global cognition. The third term shows the interaction of baseline UI with Time; this coefficient quantifies the association of UI with the annual rate of change in global cognition. The model also included six additional terms to control for the effect of demographic variables, age, sex, and education. Three terms indicated the cross-sectional association of age, sex, and education with the level of baseline cognition. An additional three terms quantify their interactions with Time; these coefficients represent the association of UI with the rate of change in global cognition.
Regression models which controlled for age and sex were used to examine the association of UI with summary measures for brain pathology. The a priori level of statistical significance was .05. Analyses were validated graphically and analytically. Models were programmed using SAS Version 9.3 (31).
Results
Descriptive Characteristics of UI at Baseline
There were 2,617 participants in these analyses; their clinical characteristics at baseline are summarized in UI was modestly associated with age (Spearman's ρ = .11, p < .001), more common in women than men (52.0% vs 35.7%, chi-square, 53.1, df = 1, p < .001) but not with education (Spearman's ρ = .003, p = .875).
UI and Adverse Health Outcomes
The mean follow-up of time of the participants was nearly 8 years (mean = 7.74, SD = 5.14). We employed a Cox proportional hazards model adjusted for age, sex, and education to examine the association of baseline UI with incident parkinsonism. Baseline UI was associated with incident parkinsonism (Table 2 ). Since we treated UI as a numerical scale, inspection of the hazard ratio suggests that an individual with severe incontinence (episodes on 5-7 days/week), had about a 30% increased risk of developing parkinsonism as compared to an individual without incontinence.
Since the pathologic basis for parkinsonism in older adults with and without a clinical diagnosis of PD may vary (10), we repeated this analysis excluding 65 cases with a clinical diagnosis of PD. Baseline UI remained associated with incident parkinsonism (Table 2) . In a final model, adding terms for seven chronic health conditions and BMI did not attenuate the association of UI with incident parkinsonism (Table 2) .
In further analyses, we examined whether baseline UI was associated with other adverse health outcomes. Baseline UI was also associated with risk of death and incident ADL and mobility disability, but was not associated with incident MCI or AD dementia (Table 2 ). These findings were unchanged when we controlled for seven chronic health conditions and BMI (Table 2) .
To interpret the magnitude of the higher risk of adverse health outcomes associated with each point in baseline UI, we compared the hazard ratio of UI to the hazard ratio of age at baseline which was also associated with incident adverse health outcomes. The increased risk of parkinsonism, disability, and death associated with each one-point increase of the frequency of baseline UI was similar to the higher risk of these adverse health outcomes associated with being 9-12 months older at baseline (9 months per point: parkinsonism, mobility disability, and death; 12 months older per point: ADL disability).
To ensure that diagnostic imprecision did not account for the lack of association between UI and incident cognitive impairment, we employed a linear mixed-effect model which included terms for age, sex, education and UI to examine both the cross-sectional and longitudinal associations of UI with the level and rate of change of global cognition.
On average, the global cognitive score (baseline mean = 0.10, SD = .53) declined a mean of 0.07-unit per year; about 13% of the baseline SD. Thus, over the course of a decade, this rate of decline would correspond to a decrease of 1.32 SD units. This represents a substantial loss of function, corresponding to a change in percentile (relative to all participants at study baseline) from the 50th percentile to approximately the 10th percentile. For comparison with a more common cognitive metric, the average annual rate of change in the Mini-Mental Status Exam score was −0.52 points/year. Thus, over the course of a decade, an individual with a baseline score of 28.2 would decrease to a score of 23.
The annual rate of cognitive decline was more rapid in older participants older and less rapid in those with more education and men displayed slightly more rapid decline. UI at baseline was not associated with the estimated baseline level of cognition or its annual rate of cognitive decline (Table 3) .
Postmortem Indices of Brain Pathologies and UI Proximate to Death
Of the 1,220 deaths there were 1,037 brain autopsies (85% autopsy rate) and 1,024 (84.0%) on whom a uniform brain autopsy was complete at the time of these analyses. At their last visit, about 10 months before death, more than 65% had UI. One or more age-related neuropathologies (Table 1) We examined regression models which controlled for age and sex to examine whether UI proximate to death was associated with postmortem brain indices. Interestingly, only Lewy body pathology and nigral neuronal loss were associated with UI (Table 4) . Since these Lewy body pathology and nigral neuronal loss are associated with PD, we repeated the analyses excluding persons with clinically diagnosed PD (N = 39) and the results were unchanged (Table 4) .
Discussion
In this study of more than 2,500 community-dwelling individuals who were on average almost 80 years old and without clinical dementia, more than 45% of participants reported some degree of UI. The frequency of UI at baseline was associated with incident parkinsonism as well as survival and incident disability. By contrast, UI was not associated with incident MCI or incident AD dementia or with the rate of cognitive decline. In addition, in decedents who underwent brain autopsy, we found that among older adults who died, the frequency of UI proximate to death was associated with an increased burden of PD pathology including both Lewy body pathology and nigral neuronal loss. UI proximate to death was not associated with other neuropathologies including AD, TDP-43, and several cerebrovascular disease pathologies.
The current study fills several important gaps in our knowledge about the association of UI with adverse health outcomes in older adults. First, while prior studies have linked UI with the risk of death and incident disability (32) (33) (34) , the current study found that UI is associated with incident parkinsonism in older adults. Second, although prior studies report that UI in older adults with dementia is associated with a more rapid rate of progression of dementia, we are unaware of prior studies which have examined the association of UI in older adults without dementia with incident MCI and AD (3,32,33,35-39) . Leveraging extensive cognitive testing, the current study found that UI was not associated with either incident MCI or incident AD dementia. Further, to ensure that diagnostic imprecision did not account for these results, a complementary analysis which employed a composite measure of global cognition showed that UI was not associated with either the level or the rate of change in cognitive function, the principal manifestation of incident dementia such as AD. The association of UI with some (survival, disability, and parkinsonism) but not all adverse health outcomes (cognitive impairments) in older adults needs to be replicated in other studies and further work is needed to understand the biology underlying these dissociations.
Urinary control depends on the orchestration of sensory, and voluntary and autonomic motor control via widely distributed central and peripheral neural networks which control the urinary tract and bladder (40) (41) (42) . Thus, the accumulation of neuropathology in a wide range of micturition-related CNS regions may lead to UI. Recent work in these cohorts and by others suggests that indices of age-related brain neuropathologies which accumulate in older adults are associated with parkinsonism and other motor and cognitive symptoms (24, 29, (43) (44) (45) . Our prior work suggests that the pathologic basis for parkinsonism in older adults with and without a clinical diagnosis of PD may vary. PD, which affects <5% of older adults by age 85 years, is associated with PD pathology (Lewy body pathology in the substantia nigra and nigral neuronal loss) (46) . In contrast, "parkinsonism" which affects more than 50% or more of adults 85 years or older is more likely to be associated with indices of non-PD brain pathology including cerebrovascular disease pathologies or neurodegenerative disorders like Alzheimer's disease pathology (10) .
The current study extends prior work by providing evidence that UI in older adults without a clinical diagnosis of PD is associated with PD pathology (Lewy bodies and nigral neuronal loss). There is increasing recognition that urinary complaints may occur years before the classic motor signs in PD (5) . Recent work has shown that in PD, Lewy body pathology may accumulate not only in the brain but throughout the distributed urinary network which extends from the sacral spinal structures to the brainstem (47) . While PD pathology in the brain was associated with UI proximate to death, given its small effect size, it will be necessary to determine the extent to which the accumulation of PD pathology in nonbrain regions of the distributed urinary network might account for a larger amount of the variance of UI proximate to death. Other neuropathologies not measured in the current study such as white matter abnormalities and assessments of nonbrain locations may explain in part why UI is associated with some but not all adverse health outcomes in older adults.
Recent studies suggest that UI and other geriatric syndromes including falls, physical frailty, and disability may share common features which may account for their co-occurrence in older adults. Like UI, these geriatric syndromes may share an underlying biology such as the accumulation of brain neuropathology (48) . The varied locations within the CNS which accumulate neuropathologies may contribute to the varied geriatric syndromes and clinical signs which manifest in older adults (49, 50) . Finally, the current findings in older adults without a clinical diagnosis of PD may inform on efforts to † The upper row in each cell gives the results for all older adults included in these analyses.
† † The middle row in each cell gives the results from a series of sensitivity analyses in which we excluded all cases with a clinical history of PD (N = 65).
‡ The bottom row in each cell are the results from a series of analyses to examine potential residual confounding by controlling for seven chronic health conditions (hypertension, diabetes, myocardial infarction, stroke, cancer, thyroid disorder, and head trauma) with linear and quadratic terms for BMI. delineate the prodromal PD (5). The current study suggests that the accumulation of PD pathology may affect a much larger number of older adults, who manifest varying degrees of non-motor deficits like UI in combination with mild motor impairments not severe enough for a traditional diagnosis of PD. Further efforts to characterize preclinical and prodromal PD may require the development of clinical risk profiles which incorporate quantitative clinical measures, neuroimaging, genetic, biochemical biomarkers, and other diagnostic tests to increase the specificity for predicting distinct pathologies and etiologies associated with the heterogeneous manifestations of parkinsonism in older adults.
The current study has several limitations. The selected nature of the cohorts which only includes participants willing to provide organ donation underscores the need to replicate these results in a more general population. The observational nature of the study limits causal inferences.
Only self-report data were assessed without physiological data such as urodynamic tests, so we cannot study whether particular urinary disorders might account for these results. While, this study assessed the frequency of UI, information about the type of incontinence (i.e., stress, urge, or mixed) was not available. Since the biology of different types of incontinence may differ, additional studies which examine both frequency and type of incontinence are needed and could yield different associations with cognitive impairment. Finally, this study was large though on an individual level the effect sizes are small. Nonetheless, from a public policy perspective given the extent of UI in old age, even the modest effect sizes observed in the current study are likely to be of public health importance.
While these findings were statistically significant, nigral neuronal loss and Lewy body pathology explained only a modest amount of the variation of UI in the current study (48, 51) . There are several reasons why our study may have underestimated the contributions of these pathologies to UI. First, the post-mortem indices were preferentially collected from traditional cognitive-related brain regions, while other micturition-related regions rostral and caudal to the substantia nigra were not examined and are likely to make separate contributions. Furthermore, other relevant pathologies, such as white matter loss, were not measured. Further studies are needed to replicate these findings and to determine which other neuropathologies and CNS regions are associated with UI in old age.
The current study has several strengths. Use of a community-based sample, rather than a clinic series, reduces selection bias. Uniform, structured clinical, and postmortem procedures were followed. Autopsy rates were very high and all postmortem evaluations were performed by examiners blinded to all clinical data. Finally, while objective urodynamic data might have yielded interesting results, self-report measurements remain the most widely used measures in community surveys and this study shows that they identify older individuals with decreased survival and increased burden of brain pathology.
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